EPIXTRA 50 IV (Epirubicin HCL Injection 50mg) x 1 VIAL.

EPIXTRA 50 IV (Epirubicin HCL Injection 50mg) x 1 VIAL. Brand Name: Zydus Generic Name: Epirubicin. Class: Anticancer agent (Anthracycline). Pack Size: 1 vial containing 50mg of epirubicin. Form: Sterile solution for intravenous use. Strength: Each vial contains 50mg of epirubicin. Amount: ₦‎15,500. Description: Epixtra is used as an adjuvant treatment for breast cancer. It belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of cancer cells. Close monitoring of liver function and blood cell count is necessary while receiving this medication. Key Features: • Effective against breast cancer. • Administered via intravenous infusion. Side Effects: • Nausea, vomiting, diarrhoea, abdominal pain, flushing, or skin/nail colour changes may occur. • Severe nausea and vomiting can be managed with medication. Caution: • For intravenous use only. • To be sold by retail on the prescription of an Oncologist only. • Use under the supervision of a qualified physician experienced in the use of antineoplastic therapy. • Monitor heart function regularly during treatment. • Avoid contact with skin and eyes; rinse thoroughly with water if contact occurs.